Neurizon Therapeutics Limited (ASX:NUZ)
Australia · Delayed Price · Currency is AUD 0.0730
+0.0010 (1.39%)
Jul 7, 2026, 2:19 PM AEST
Neurizon Therapeutics Market Cap
Neurizon Therapeutics has a market cap or net worth of 53.73 million as of July 6, 2026. Its market cap has decreased by -35.80% in one year.
Market Cap
53.73M
Enterprise Value
47.41M
Revenue
5.98M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.07
Market Cap Chart
Since September 12, 2002, Neurizon Therapeutics's market cap has increased from 4.18M to 53.73M, an increase of 1,184.46%. That is a compound annual growth rate of 11.31%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 7, 2026 | 53.73M | 17.98% |
| Dec 31, 2025 | 45.54M | -45.58% |
| Dec 31, 2024 | 83.69M | 94.55% |
| Dec 29, 2023 | 43.02M | 112.09% |
| Dec 30, 2022 | 20.28M | -36.00% |
| Dec 31, 2021 | 31.69M | -4.63% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Avecho Biotechnology | 88.10M |
| Arovella Therapeutics | 83.41M |
| Immutep | 81.05M |
| Amplia Therapeutics | 77.00M |
| Prescient Therapeutics | 71.50M |
| Radiopharm Theranostics | 70.88M |
| Nexsen | 61.06M |
| Botanix Pharmaceuticals | 57.42M |